Posted by Michael Wonder on 01 Jan 2021

Schedule of Pharmaceutical Benefits - 1 January 2021 update

Australian Government

1 January 2021 - The January 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.

The January issue of the Schedule includes a few new/revised listings:

  • Apremilast (Otezla) - new medicine
  • Dararumumab (Darzalex) - new medicine
  • Osimertinib mesylate (Tagrisso) - new indication

Read Summary of Changes

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , Listing , Australia , Market access